← Open Payments lookup

CARL DEFRANCO: Open Payments

NPI 1033777867 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,533 in 120 payments from 15 companies in 2025. Trend: 2023 $7,999 · 2024 $13,731 · 2025 $4,533

Food & beverage: $2,463Speaker / faculty: $1,971Education: $100
CompanyPaymentsAmount
Otsuka Pharmaceutical Development & Commercialization, Inc.5$2,145
Otsuka America Pharmaceutical, Inc.50$922
E.R. Squibb & Sons, L.L.C.16$307
Neurocrine BioSciences, Inc.8$273
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$208
Alkermes, Inc.8$184
MERZ NORTH AMERICA, INC.5$165
Teva Pharmaceuticals USA, Inc.4$139
Luye Pharma (USA) Ltd.3$59
Biogen, Inc.1$27

Products named: ABILIFY ASIMTUFII, REXULTI, COBENFY, INGREZZA, CAPLYTA, ARISTADA, Xeomin, ABILIFY MAINTENA.

Industry payments across NY — which companies pay providers there.